Literature DB >> 2703255

The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.

R A Kay1, A Ferguson.   

Abstract

Immunization of adult BALB/c mice with 1 microgram cholera toxin (CT) in complete Freund's adjuvant (CFA) induced both humoral (IgG and IgA) and cell-mediated (DTH) immunity. Although an immunopurified, formalinized, cholera toxoid (TD) in CFA was inferior to the native holotoxin at inducing antitoxin antibodies, both cholera-derived antigens were equally immunogenic for specific DTH. When mice were fed either 1 microgram CT or 5 microgram TD 1 week before immunization, the induction of DTH was inhibited but the development of specific antibody was the same as in sham-fed controls. A feed of 10 micrograms CT not only suppressed the induction of DTH but also enhanced the IgG antitoxin responses measured 1 week after immunization. A dose of TD (50 micrograms), with a similar cholera toxin B subunit content, also induced oral tolerance for DTH but had no effect on the subsequent development of humoral immunity. The smallest doses of CT or TD fed (0.1 microgram and 0.5 microgram, respectively) failed to affect the development of either limb of the systemic immune response. These results suggest that oral tolerance for DTH is not consequent upon the metabolic actions of CT but that stimulation of systemic antibodies after enteric administration may be. Pretreating mice with cyclophosphamide (Cy) (100 mg/kg) before feeding CT abrogated the induction of oral tolerance for DTH but had no effect on humoral immunity, suggesting that suppressor T cells may be responsible for the induction of oral tolerance in these animals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703255      PMCID: PMC1385229     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  In vivo induction of carrier-specific cyclophosphamide-sensitive suppressor cells for cell-mediated immunity in mice.

Authors:  A M Attallah; A Ahmed; K W Sell
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

2.  Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.

Authors:  C O Elson; W Ealding
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

Review 3.  Cholera and the immune response.

Authors:  J Holmgren; A M Svennerholm
Journal:  Prog Allergy       Date:  1983

4.  Protection against experimental cholera in the rat. A study on the formation of antibodies against cholera toxin and desensitization of adenylate cyclase after immunization with cholera toxin.

Authors:  S Lange; I Lönnroth; H Nygren
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

5.  Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin.

Authors:  S D Miller; D G Hanson
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

6.  Immunological responses to fed protein antigens in mice. IV. Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin.

Authors:  A M Mowat; D M Parrot
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

7.  Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide.

Authors:  A M Mowat; S Strobel; H E Drummond; A Ferguson
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

8.  Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen.

Authors:  S Strobel; A M Mowat; H E Drummond; M G Pickering; A Ferguson
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

9.  Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune responses.

Authors:  T Diamantstein; M Klos; H Hahn; S H Kaufmann
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

10.  Special features of the priming process for a secretory IgA response. B cell priming with cholera toxin.

Authors:  J A Fuhrman; J J Cebra
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  7 in total

1.  T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division.

Authors:  Karen M Smith; Joanne M Davidson; Paul Garside
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

2.  Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance.

Authors:  H Bakke; K Lie; I L Haugen; G E Korsvold; E A Høiby; L M Naess; J Holst; I S Aaberge; F Oftung; B Haneberg
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Oral tolerance.

Authors:  W Strober; B Kelsall; T Marth
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

Review 4.  Oral tolerance.

Authors:  H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

Review 5.  Mechanism of oral tolerance induction to therapeutic proteins.

Authors:  Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

6.  The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH.

Authors:  R A Kay; A Ferguson
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

7.  Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression.

Authors:  M C Braun; J He; C Y Wu; B L Kelsall
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.